Related Experiment Video

Updated: Jul 27, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:08

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

112

Roles, biological functions, and clinical significances of RHPN1-AS1 in cancer

Fan Yu1, Haihong He1, Yiwen Zhou1

  • 1Clinical Laboratory Medical Center, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, China.

Pathology, Research and Practice
|June 7, 2023
PubMed

Insights

Long non-coding RNAs (lncRNAs) are key in cancer. RHPN1-AS1, a specific lncRNA, is overexpressed in cancers and drives tumor growth, highlighting its potential as a therapeutic target.

Area of Science:

  • Molecular biology
  • Cancer research
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
  • Understanding lncRNA functions is crucial for developing targeted cancer therapies.
  • RHPN1-AS1 is a lncRNA implicated in various cancers.

Purpose of the Study:

  • To review the biological and clinical functions of RHPN1-AS1 in cancer.
  • To consolidate current knowledge on RHPN1-AS1's role in cancer development.
  • To highlight RHPN1-AS1 as a potential therapeutic target.

Main Methods:

  • Literature review of studies on RHPN1-AS1 in cancer.
  • Analysis of gene expression data in cancer cell lines.
  • Examination of RHPN1-AS1's impact on cellular functions and pathways.

Main Results:

  • RHPN1-AS1 is significantly upregulated in uveal melanoma and other cancer cell lines.
  • RHPN1-AS1 exhibits oncogenic functions, promoting cancer development.
  • RHPN1-AS1 influences gene expression, protein localization, and chromatin remodeling.

Conclusions:

  • RHPN1-AS1 plays a significant role in the pathogenesis of various cancers.
  • RHPN1-AS1 represents a promising biomarker and therapeutic target for cancer treatment.
  • Further research into RHPN1-AS1's mechanisms is warranted.
Keywords:
BiomarkerCancerLncRNANon-coding-RNARHPN1-AS1

More Related Videos

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

8.0K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.1K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.0K